BIOMAT Database Logo BIOMAT Database Logo

Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs. 2021

Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.

UI MeSH Term Description Entries
D009305 Nasopharynx The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function. Rhinopharynx,Choanae,Nasopharynges,Nasopharynxes,Rhinopharynges,Rhinopharynxes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067716 Point-of-Care Testing Allows patient diagnoses in the physician’s office, in other ambulatory setting or at bedside. The results of care are timely, and allow rapid treatment to the patient. (from NIH Fact Sheet Point-of-Care Diagnostic Testing, 2010.) Bedside Testing,Point-Of-Care Diagnostic Testing,Point-Of-Care Diagnostic Tests,Point-Of-Care Diagnostics,Point-Of-Care Test,Point-Of-Care Tests,Point of Care Testing,Diagnostic Test, Point-Of-Care,Diagnostic Testing, Point-Of-Care,Diagnostic Tests, Point-Of-Care,Diagnostic, Point-Of-Care,Diagnostics, Point-Of-Care,Point Of Care Diagnostic Testing,Point Of Care Diagnostic Tests,Point Of Care Diagnostics,Point Of Care Test,Point Of Care Tests,Point-Of-Care Diagnostic,Point-Of-Care Diagnostic Test,Test, Point-Of-Care,Test, Point-Of-Care Diagnostic,Testing, Bedside,Testing, Point-Of-Care Diagnostic,Testing, Point-of-Care,Tests, Point-Of-Care,Tests, Point-Of-Care Diagnostic
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000087123 COVID-19 Nucleic Acid Testing Diagnosis of COVID-19 by assaying bodily fluids or tissues for the presence of the VIRAL RNA of SARS-COV-2. COVID-19 RT-PCR Testing,COVID19 Nucleic Acid Testing,SARS Coronavirus 2 Nucleic Acid Testing,SARS Coronavirus 2 RT-PCR Testing,SARS-CoV-2 Infection Nucleic Acid Testing,SARS-CoV2 RT-PCR Testing,COVID 19 Nucleic Acid Testing,COVID 19 RT PCR Testing,COVID-19 RT-PCR Testings,RT-PCR Testing, COVID-19,RT-PCR Testing, SARS-CoV2,SARS CoV 2 Infection Nucleic Acid Testing,SARS CoV2 RT PCR Testing,SARS Coronavirus 2 RT PCR Testing,SARS-CoV2 RT-PCR Testings,Testing, COVID-19 RT-PCR,Testing, SARS-CoV2 RT-PCR
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D060888 Real-Time Polymerase Chain Reaction Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction. Kinetic Polymerase Chain Reaction,Quantitative Real-Time PCR,Quantitative Real-Time Polymerase Chain Reaction,Real-Time PCR,PCR, Quantitative Real-Time,PCR, Real-Time,PCRs, Quantitative Real-Time,PCRs, Real-Time,Quantitative Real Time PCR,Quantitative Real Time Polymerase Chain Reaction,Quantitative Real-Time PCRs,Real Time PCR,Real Time Polymerase Chain Reaction,Real-Time PCR, Quantitative,Real-Time PCRs,Real-Time PCRs, Quantitative
D019411 Clinical Laboratory Techniques Techniques used to carry out clinical investigative procedures in the diagnosis and therapy of disease. Clinical Laboratory Test,Clinical Laboratory Testing,Clinical Laboratory Diagnoses,Clinical Laboratory Testings,Clinical Laboratory Tests,Diagnoses and Laboratory Examinations,Diagnosis, Laboratory,Laboratory Diagnosis,Laboratory Examinations and Diagnoses,Laboratory Techniques, Clinical,Clinical Laboratory Technique,Diagnose, Clinical Laboratory,Laboratory Diagnoses,Laboratory Technique, Clinical,Laboratory Test, Clinical,Laboratory Testing, Clinical,Technique, Clinical Laboratory,Test, Clinical Laboratory,Testing, Clinical Laboratory
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.
July 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
July 2021, Journal of medical virology,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
February 2021, Diagnostic microbiology and infectious disease,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay.
April 2022, Pathology,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
July 2020, Journal of clinical microbiology,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay.
February 2022, Pathology,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay.
September 2022, Journal of medical virology,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Clinical evaluation of a modified SARS-CoV-2 rapid molecular assay, ID NOW ™ COVID-19 2.0.
March 2024, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.
July 2020, Journal of clinical microbiology,
Virian D Serei, and Ryan Cristelli, and Kim Joho, and Gratian Salaru, and Thomas Kirn, and Mary O Carayannopoulous, and Priyanka Uprety
Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage.
June 2022, Journal of clinical virology plus,
Copied contents to your clipboard!